Bausch + Lomb Corporation share price logo

Bausch + Lomb Corporation

NYSE: BLCO

Mid Cap

$17.30

+0.15

(+0.87%)

as on

Bausch + Lomb Corporation Stock Performance

as on October 12, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $17.23
    $17.47
    downward going graph

    0.40%

    Downside

    0.98%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $14.39
    $18.92
    downward going graph

    16.82%

    Downside

    9.34%

    Upside

    downward going graph

Bausch + Lomb Corporation share price movements today

Previous Close
$17.15
Open
$17.33
Volume
211.5K
Market Cap
$6.2B
Day's Low - High
$17.23 - $17.47
52 Week Low - High
$14.39 - $18.92

Bausch + Lomb Corporation Historical Returns

1 Month Return
+ 0.29 %
3 Month Return
+ 6.59 %
1 Year Return
+ 20.81 %
3 Year Return
+ 3.72 %
5 Year Return
0 %

Bausch + Lomb Corporation Stock Fundamentals & Key Indicators

Check Bausch + Lomb Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.2B

EPS (TTM)

-0.4782

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.89%

PE Ratio (TTM)

-36.18

Industry PE ratio

38.38

PEG Ratio

-1.45

EBITDA

742.0M

Revenue (TTM)

5.3B

Profit Margin

57.23%

Return On Equity TTM

-2.67%

Bausch + Lomb Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bausch + Lomb Corporation with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Bausch + Lomb Corporation image
Bausch + Lomb Corporation
Buy$6.2BNA-36.1857.23%0.00%
Resmed image
Resmed
Neutral$32.4B-8.80%22.0461.16%1.07%
Intuitive Surgical image
Intuitive Surgical
StrongBuy$149.8B30.67%47.9166.68%0.00%
Becton Dickinson image
Becton Dickinson
Neutral$50.1B-22.92%55.3546.12%2.16%
Medline image
Medline
StrongBuy$48.8BNA42.1625.02%0.00%

Stock Returns calculator for Bausch + Lomb Corporation Stock including INR - Dollar returns

The Bausch + Lomb Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Bausch + Lomb Corporation investment value today

Current value as on today

₹1,30,477

Returns

₹30,477

(+30.48%)

Returns from Bausch + Lomb Corporation Stock

₹20,810 (+20.81%)

Dollar Impact

₹9,667 (+9.67%)

Analyst Recommendation on Bausch + Lomb Corporation Stock

Based on 6 analysts

BUY

33.33%

Buy

66.67%

Hold

0.00%

Sell

Based on 6 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for Bausch + Lomb Corporation. Average target price of $19.39

Bausch + Lomb Corporation Share Price Target

Get share price movements and forecasts by analysts on Bausch + Lomb Corporation.

What analysts predicted

10.78%UPSIDE

Target Price

$19.39

Current Price

$17.3

Analyzed by

6 Analysts

High

$24

Target

$19.39

Low

$16

Bausch + Lomb Corporation target price $19.39, a slight upside of 10.78% compared to current price of $17.3. According to 6 analysts rating.

Indian Investors' Interest in Bausch + Lomb Corporation Stock

Search interest for Bausch + Lomb Corporation Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-50% versus previous 30 day period

Bausch + Lomb Corporation Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1,099
1,216
1,196
1,280
1,137
1,278
1,281
1,405
1,244
1,389
Gross Profit
675
733
732
779
588
686
703
816
704
821
Operating Income
6
26
43
87
-61
11
80
158
59
83
EBITDA
119
150
152
194
23
91
209
212
137
184
Interest Expense
99
102
100
98
97
131
103
100
100
93
Depreciation
110
110
110
106
106
107
109
99
101
102
Income Before Tax
-90
-76
-58
-10
-180
-147
-3
13
-64
-11
Income Tax Expense
73
72
-66
-8
31
-89
22
71
6
-1
Net Income
-167
-151
4
-3
-212
-62
-28
-58
-71
-14
Net Profit Margin
61.42%
60.28%
61.20%
60.86%
51.72%
53.68%
54.88%
58.08%
56.59%
59.11%

Bausch + Lomb Corporation Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
3,778
3,412
3,765
3,768
4,146
4,791
5,101
Gross Profit
2,451
2,127
2,298
2,249
2,504
2,919
2,793
Operating Income
396
260
329
207
130
162
188
EBITDA
936
732
733
598
499
601
535
Interest Expense
-
-
-
146
283
399
431
Depreciation
469
442
415
379
382
436
421
Income Before Tax
399
290
318
73
-166
-234
-317
Income Tax Expense
96
307
125
58
82
71
35
Net Income
298
-18
182
6
-260
-317
-360
Net Profit Margin
64.88%
62.34%
61.04%
59.69%
60.40%
60.93%
54.75%

Bausch + Lomb Corporation Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-163
-148
8
-2
-211
-58
-28
-58
-71
-10
Operating Cash Flow
41
15
154
22
-25
35
139
134
32
153
Investing Cash Flow
-57
-74
-96
-185
-116
-90
-61
-184
-130
-87
Financing Cash Flow
12
40
-20
146
31
90
-12
114
-20
34
Change in Cash
-9
-23
48
-34
-101
57
60
65
-118
99

Bausch + Lomb Corporation Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
303
-17
193
15
-248
-305
-352
Operating Cash Flow
799
522
873
345
-17
232
283
Investing Cash Flow
-186
-256
-214
-215
-2,109
-412
-455
Financing Cash Flow
-606
-232
-712
81
2,078
178
225
Change in Cash
4
46
-61
203
-46
-18
81

Global Institutional Holdings in Bausch + Lomb Corporation

Check out the Institutions with significant holdings in Bausch + Lomb Corporation.

Funds
Holdings
Carl Icahn
0.98%
Steven A. Tananbaum
0.74%
Edward A Mule
0.63%
Nader Motamedy
0.56%
Larry Robbins
0.54%
See all

Bausch + Lomb Corporation News & Key Events

  • img

    Today's Timeline - 12 October

    Mon, 04:20 PM

    -

    Bausch + Lomb and Bausch Health expect to raise full-year 2026 adjusted EBITDA guidance, details to follow on Oct. 28.

    Mon, 04:21 PM

    -

    Thomas Appio appointed interim CEO of Bausch + Lomb, while continuing as CEO of Bausch Health.

Insights on Bausch + Lomb Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, BLCO has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -71.00M → -14.0M (in $), with an average increase of 407.1% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.24B → 1.38B (in $), with an average increase of 10.4% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, BLCO stock has moved up by 0.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, ResMed Inc. has given 59.3% return, outperforming this stock by 55.6%

About Bausch + Lomb Corporation

Bausch + Lomb Corporation is a leading global eye health company. Its operations are structured across three primary segments: Vision Care/Consumer Health, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health division offers a comprehensive portfolio of contact lenses, encompassing all wearing modalities from daily disposables to frequently replaced options. This segment also provides essential contact lens care products, over-the-counter eye drops, and nutritional supplements aimed at alleviating common eye conditions like allergies, conjunctivitis, and dry eye. Through its Ophthalmic Pharmaceuticals segment, the company develops and markets both proprietary and generic prescription medications. These pharmaceuticals are utilized for post-operative recovery and the treatment of various ocular diseases, such as glaucoma, ocular hypertension, and retinal disorders. Additionally, it supplies therapeutic contact lenses. The Surgical segment is dedicated to providing advanced tools and technologies for surgical interventions related to cataracts, as well as vitreous and retinal conditions. Its offerings include intraocular lenses (IOLs) with their delivery systems, phacoemulsification equipment, and a range of other specialized surgical instruments and devices. Founded in 1853, Bausch + Lomb is headquartered in Vaughan, Canada.
OrganisationBausch + Lomb Corporation
Headquarters520 Applewood Crescent, Vaughan, ON, L4K 4B4, CA
IndustryMedical - Instruments & Supplies
CEOBrenton L. Saunders

Key Management of Bausch + Lomb Corporation

Name

Title

Mr. George Gadkowski

VP & Head of Investor Relations & Business Insights

Mr. Brenton L. Saunders J.D.

CEO & Director

Mr. Osama A. Eldessouky

Executive VP & CFO

Mr. Andrew J. Stewart

President of Global Pharmaceuticals & International Consumer

Mr. Frederick J. Munsch

Senior VP, Controller & Chief Accounting Officer

Mr. Jonathon L. Kellerman

Chief Compliance Officer

Mr. T.J. Crawford

Chief Communications Officer

Mr. A. Robert D. Bailey

Executive VP & Chief Legal Officer

Dr. Yehia Hashad M.D., Ph.D.

Executive VP of Research & Development and Chief Medical officer

Mr. Alan Waterhouse CPFA, MBA

Executive VP and Chief Supply Chain & Operations Officer

FAQs

What is Bausch + Lomb Corporation share price today?

Bausch + Lomb Corporation share price today is $17.30 as on at the close of the market. Bausch + Lomb Corporation share today touched a day high of $17.47 and a low of $17.23.

What is the 52 week high and 52 week low for Bausch + Lomb Corporation share?

Bausch + Lomb Corporation share touched a 52 week high of $18.92 on and a 52 week low of $14.39 on . Bausch + Lomb Corporation stock price today i.e. is closed at $17.30,which is 8.54% down from its 52 week high and 20.22% up from its 52 week low.

What is Bausch + Lomb Corporation's market capitalisation today?

Bausch + Lomb Corporation market capitalisation is $0.01T as on .

How to invest in Bausch + Lomb Corporation Stock (BLCO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bausch + Lomb Corporation on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Bausch + Lomb Corporation Stock (BLCO) from India?

Indian investors can start investing in Bausch + Lomb Corporation (BLCO) shares with as little as ₹95.76000213623047 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.60 in Bausch + Lomb Corporation stock (as per the Rupee-Dollar exchange rate as on ). Based on Bausch + Lomb Corporation share’s latest price of $17.30 as on October 12, 2026 at 8:46 am IST, you will get 0.5780 shares of Bausch + Lomb Corporation. Learn more about fractional shares .